Heartburn is one of the most commonly reported side effects among patients taking semaglutide (Ozempic, Wegovy, Rybelsus), a GLP-1 receptor agonist used for type 2 diabetes and weight management
Directly engaging patients by providing them with resources and information, empowers them to make decisions on their healthcare before they even consult their providers
Tucson: University of Arizona
Treatment selection and dosing are determined by a licensed clinician based on the patients intake and medical history
To our knowledge, no retrospective studies have been conducted to assess the effectiveness of semaglutide at the doses used to treat obesity (ie, 1.7 and 2.4 mg). Researchers conducted a cohort study at a referral center for weight management and included 175 patients (mean age, 49.3 years
Screenings can identify polyps before they become cancerous and can catch cancer earlier when it is more easily treatable